AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Xyotax has potential to be first modified taxane launched in major markets.
2003 JUL 3 - (NewsRx.com & NewsRx.net) -- Decision Resources, Inc., finds Cell Therapeutics' ovarian cancer (CaO) drug Xyotax has the potential to be the first modified taxane to be launched in major pharmaceutical markets (United States, France, Germany, Italy, Spain, United Kingdom, and Japan).
Xyotax is the only modified taxane to have reached phase III development for CaO, making it most likely to achieve first-to-market status in this indication. However, according to the new Pharmacor study entitled "Ovarian Cancer," the modified taxane pipeline is burgeoning with candidates including agents by Bristol-Myers Squibb and American Pharm Partners.
"Clinicians we spoke to for this study predict that modified versions of existing classes of ...
- Cell Therapeutics' Ovarian Cancer Drug Xyotax Has Potential To Be The First...
- Press release article from: PR Newswire June 3, 2003 700+ words
...PRNewswire/ -- Decision Resources, Inc...the first modified taxane to be launched...is the only modified taxane to have reached...Cancer, the modified taxane pipeline is...analyst at Decision Resources. Disease...
- Decision Resources, Inc. Acquires Millennium Research Group.
- Press release article from: PR Newswire February 2, 2006 700+ words
Acquisition Expands Decision Resources' Healthcare Market Research...Co-Presidents of the New Decision Resources Subsidiary WALTHAM, Mass...Feb. 2 /PRNewswire/ -- Decision Resources, Inc., one of the world...
- Decision Resources, Inc. Acquires Fingertip Formulary.
- Press release article from: PR Newswire March 17, 2008 700+ words
Acquisition Expands Decision Resources, Inc.'s Offering to Include...March 17 /PRNewswire/ -- Decision Resources, Inc., one of the world...Formulary by Waltham, MA-based Decision Resources, Inc. will result in a significant...
- Decision Resources Inc. to Acquire Wood Mackenzie's Life Sciences Business.
- Press release article from: PR Newswire December 4, 2007 700+ words
...Acquisition Will Accelerate Decision Resources Inc.'s Commercial Expertise...Dec. 4 /PRNewswire/ -- Decision Resources, Inc., one of the world...The acquisition is part of Decision Resources Inc.'s overall growth...
- Decision Resources, Inc. Acquires Arlington Medical Resources, Inc.
- Press release article from: PR Newswire December 19, 2007 700+ words
Acquisition Expands Decision Resources, Inc.'s Market Research...Dec. 19 /PRNewswire/ -- Decision Resources, Inc., one of the world...AMR by Waltham, MA-based Decision Resources, Inc. will result in a significant...
- Decision Resources, Inc. Acquires Manhattan Research.
- Press release article from: PR Newswire June 17, 2008 700+ words
Acquisition Expands Decision Resources, Inc.'s Portfolio to Include...June 17 /PRNewswire/ -- Decision Resources, Inc., one of the world...Research by Waltham, MA-based Decision Resources, Inc. will result in a significant...
- Angiomax Will Retain Decision Resources' Proprietary Clinical Gold Standard...
- Press release article from: PR Newswire February 25, 2009 700+ words
...According to a New Report from Decision Resources WALTHAM, Mass., Feb. 25 /PRNewswire/ -- Decision Resources, one of the world's leading...cardiologists. Angiomax, which was Decision Resources' proprietary clinical gold standard...
- Decision Resources' Updated Rheumatoid Arthritis Report Now Includes Forecast...
- Press release article from: PR Newswire August 6, 2009 700+ words
...Mass., Aug. 6 /PRNewswire/ -- Decision Resources, one of the world's leading research...premium-priced biologics. However, Decision Resources conservatively forecasts that fostamatinib...3 inhibitor CP-690550," said Decision Resources Analyst Joanna Kim, M.Ed. "Fostamatinib...
Source: HighBeam Research, Xyotax has potential to be first modified taxane launched in major...